ABVC BioPharma Inc.

NASDAQ: ABVC · Real-Time Price · USD
2.87
-0.26 (-8.31%)
At close: Aug 19, 2025, 3:59 PM
2.91
1.39%
After-hours: Aug 19, 2025, 07:18 PM EDT

ABVC BioPharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-5.26M -10.52M -16.31M -12.04M
Depreciation & Amortization
200.92K 28.53K 23.8K 11.99K
Stock-Based Compensation
n/a 1.64M 7.04M 5.31M
Other Working Capital
-114.46K 583.99K 1.22M -1.44M
Other Non-Cash Items
3.66M 3.52M 353.04K -91.05K
Deferred Income Tax
n/a 115.67K 864.8K 824.2K
Change in Working Capital
-408.42K 976.96K 635.57K -1.61M
Operating Cash Flow
-1.81M -4.24M -7.4M -7.6M
Capital Expenditures
n/a -21.2K -119.69K -17.5K
Cash Acquisitions
n/a -338.99K -1.6M -680.92K
Purchase of Investments
n/a n/a -1.6M -107.55K
Sales Maturities Of Investments
n/a n/a 3.2M 788.46K
Other Investing Acitivies
n/a n/a -1.6M -788.46K
Investing Cash Flow
n/a -360.19K -1.72M -805.97K
Debt Repayment
15.93K 462.62K 350K -177.74K
Common Stock Repurchased
-7.32K n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
1.94M 2.41M n/a -946.16K
Financial Cash Flow
1.98M 3.92M 4.01M 10M
Net Cash Flow
147.03K -674.95K -5.17M 1.56M
Free Cash Flow
-1.81M -4.26M -7.52M -7.62M